Emerging drugs for T-cell lymphoma

Author： Dickinson Michael   Prince Henry Miles  

Publisher： Informa Healthcare

ISSN： 1472-8214

Source： Expert Opinion on Emerging Drugs, Vol.19, Iss.2, 2014-06, pp. : 201-213

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Emerging drugs in cutaneous T cell lymphoma

By Mestel Dominik Sebastian   Assaf Chalid   Steinhoff Matthias   Beyer Marc   Moebs Markus   Sterry Wolfram  

Expert Opinion on Emerging Drugs, Vol. 13, Iss. 2, 2008-06 ,pp. : 345-361

Informa Healthcare

Access to resources Recommend Favorite

Emerging drugs in cutaneous T-cell lymphomas

By Dummer Reinhard  

Expert Opinion on Emerging Drugs, Vol. 10, Iss. 2, 2005-05 ,pp. : 381-392

Informa Healthcare

Access to resources Recommend Favorite

Current and Emerging Treatment Strategies for Cutaneous T-cell Lymphoma

By Lansigan Frederick  

Drugs, Vol. 70, Iss. 3, 2010-02 ,pp. : 273-286

Adis International

Access to resources Recommend Favorite

Romidepsin: In the Treatment of T-Cell Lymphoma

By Yang Lily P.H.  

Drugs, Vol. 71, Iss. 11, 2011-07 ,pp. : 1469-1480

Adis International

Access to resources Recommend Favorite

Management of cutaneous T-cell lymphoma

By Duhovic Chris   Child Fiona   Wain E Mary  

Clinical Medicine, Vol. 12, Iss. 2, 2012-04 ,pp. : 160-164

Royal College Of Physicians

Access to resources Recommend Favorite